Cargando…
Alzheimer’s Disease, Oligomers, and Inflammation
The production of soluble amyloid-β oligomers (AβOs) and the activation of inflammation are two important early steps in the pathogenesis of Alzheimer’s disease (AD). The central role of oligomers as responsible for the neuronal dysfunction associated with the clinical features has been extended to...
Autores principales: | Forloni, Gianluigi, Balducci, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869993/ https://www.ncbi.nlm.nih.gov/pubmed/29562537 http://dx.doi.org/10.3233/JAD-170819 |
Ejemplares similares
-
Doxycycline for Alzheimer’s Disease: Fighting β-Amyloid Oligomers and Neuroinflammation
por: Balducci, Claudia, et al.
Publicado: (2019) -
Neuroinflammation and the Gut Microbiota: Possible Alternative Therapeutic Targets to Counteract Alzheimer’s Disease?
por: Cerovic, Milica, et al.
Publicado: (2019) -
Oligomers and Neurodegeneration: New Evidence
por: Forloni, Gianluigi
Publicado: (2023) -
Oligomeropathies, inflammation and prion protein binding
por: Forloni, Gianluigi, et al.
Publicado: (2022) -
Alzheimer’s disease: from basic science to precision medicine approach
por: Forloni, Gianluigi
Publicado: (2020)